From "dangerous toxin" to the most extensively researched aesthetic treatment in medicine. Here's what decades of clinical evidence actually tells us about how botulinum toxin and dermal fillers work, why they're effective, and what makes them safe when administered properly.
25,000+
Published Research Articles
Injectable aesthetic treatments sit at an unusual intersection: they're medical procedures that have been marketed like beauty products, regulated inconsistently, and discussed in terms ranging from scientific journals to gossip magazines.
This creates confusion. Is botulinum toxin a deadly poison or a safe medical treatment? Are dermal fillers permanent or temporary? Do these treatments actually prevent aging, or just mask it temporarily?
Let's cut through the noise with biology, chemistry, and clinical research. This page goes deep into the science—how these treatments work at a cellular level, what the peer-reviewed evidence shows, and what realistic expectations look like when they're grounded in physiology rather than Instagram filters.
If you're the kind of person who wants to understand the why before the what, you're in the right place.
Section 01
Botulinum toxin type A is a neurotoxic protein produced by the bacterium Clostridium botulinum. Yes, the same bacterium that causes botulism food poisoning. This is where the "it's a poison" argument comes from, and technically, it's not wrong—in high doses, botulinum toxin is indeed dangerous.
But here's what matters: dose makes the poison. The pharmaceutical-grade botulinum toxin used in aesthetic medicine is administered in incredibly small, precisely controlled amounts—typically measured in units, with a single treatment session using 20-60 units total, depending on the area treated.10
below dangerous levels
To put this in perspective: the estimated lethal dose of botulinum toxin for humans is approximately 2,000-3,000 units if injected intravenously.11 The amount used to treat frown lines? About 20 units, injected into muscle tissue where it acts locally. We're talking about doses that are roughly 100-150 times below dangerous levels.
When botulinum toxin is injected into a muscle, it undergoes a four-stage process:12
Toxin binds to nerve receptors
Pulled inside nerve terminal
Releases active enzyme
Prevents muscle contraction
The toxin binds to receptors on the nerve endings that control muscle movement. This is highly specific—botulinum toxin targets cholinergic nerve terminals, which release acetylcholine, the neurotransmitter that tells muscles to contract.
Once bound, the toxin is pulled inside the nerve terminal through a process called receptor-mediated endocytosis. Think of it as the nerve cell unknowingly inviting the toxin inside.
Inside the nerve terminal, the toxin releases an enzyme that does the actual work: it cleaves (cuts) specific proteins called SNAP-25, which are essential for neurotransmitter release.
With SNAP-25 disabled, the nerve terminal can't release acetylcholine. No acetylcholine means no signal to the muscle. No signal means the muscle can't contract. Result: the muscle relaxes.
This isn't paralysis in the medical sense—the muscle can still move, it's just temporarily prevented from contracting with full force. The nerve terminal isn't damaged; it simply can't communicate with the muscle until it regenerates the proteins the toxin disrupted.
Injection
Effects Begin
Full Effect
Wears Off
The effects typically begin within 3-7 days and reach full effect at about 2 weeks. Duration varies, but most patients experience results for 3-4 months.13
Why does it wear off? Because your body is constantly regenerating. New nerve terminals sprout, new proteins are synthesised, and gradually, the nerve-muscle connection is restored. This is actually a safety feature—the treatment is inherently temporary and reversible through natural biological processes.
Botulinum toxin type A isn't new or experimental—it's been used in medicine since the 1980s (originally for eye muscle disorders) and approved for cosmetic use since 2002.14 This gives us over two decades of safety data specifically for aesthetic applications, plus four decades of broader medical use.
A 2024 bibliometric analysis identified over 25,000 published research articles on botulinum toxin across medical disciplines.15 For aesthetic use specifically, the evidence is particularly robust:
Clinical Study
"Treatment of glabellar lines..."
Meta-analysis, 621 patients
Published: Plastic & Reconstructive Surgery, 2024
Key Finding:
Sustained clinical benefit for 4 months in more than half of responders, with patient satisfaction increasing with duration of effect.
Glabellar lines (frown lines between eyebrows):
A meta-analysis of four randomised controlled trials involving 621 patients found that treatment with 20 units of botulinum toxin type A resulted in sustained clinical benefit for 4 months in more than half of responders, with patient satisfaction increasing with duration of effect.16
Forehead lines:
Multiple randomised trials have demonstrated statistically significant improvements in forehead wrinkle severity, with high patient satisfaction rates and minimal adverse effects.17
Crow's feet (lateral canthal lines):
Clinical trials consistently show effective wrinkle reduction lasting 3-4 months, with improvements visible both at rest and during animation (facial movement).18
Global Aesthetics Consensus Group
Panel of international plastic surgeons and dermatologists
Key recommendations:
A 2024 systematic review and meta-analysis examining clinical trials, case reports, and observational studies from 2014-2024 concluded:19
The most common side effects are:
While aesthetic medicine gets the most attention, botulinum toxin's therapeutic applications are extensive and well-documented:
This breadth of medical applications demonstrates that we're dealing with a well-characterised pharmaceutical with proven therapeutic mechanisms, not a cosmetic fad.
Section 02
Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in connective tissue, skin, and cartilage throughout the body. What makes HA remarkable is its hygroscopic nature—each molecule can hold up to 1,000 times its weight in water13. In the skin, HA is responsible for hydration, volume, and elasticity. However, our natural HA production declines by approximately 1% per year after the age of 20, contributing to visible volume loss and wrinkle formation14.
Modern dermal fillers use non-animal stabilised hyaluronic acid (NASHA), which is bioidentical to human HA but has been chemically cross-linked to resist enzymatic degradation15. This cross-linking process creates a stable gel that can be precisely injected into targeted areas to restore volume, improve skin hydration, and stimulate collagen production.
At BeReady:
We only use CE-marked, FDA-approved hyaluronic acid fillers with established safety profiles. Each product is selected based on its molecular weight, rheological properties (G' elasticity), and intended tissue plane—ensuring optimal, natural results.
The degree and type of cross-linking determine a filler's:
Poorly cross-linked fillers can migrate, appear lumpy, or degrade too quickly. Over-cross-linked fillers may feel firm, unnatural, or resist appropriate enzymatic breakdown. Premium fillers like those in the Juvéderm® Vycross range or Restylane® balance elasticity with tissue integration for predictable, natural results17.
When injected, HA fillers physically occupy space in the dermis or subcutaneous tissue, restoring lost volume and smoothing wrinkles. This effect is instant and visible immediately post-treatment18.
HA attracts water molecules, increasing dermal hydration and improving skin texture and elasticity. This is particularly beneficial in areas with superficial fine lines or crepey skin19.
Studies show that HA fillers trigger a fibroblast response, leading to new collagen and elastin production over weeks to months. This means results can actually improve beyond the filler volume alone20.
In one 2021 histological study, patients who received HA filler showed a 37% increase in dermal collagen density at 6 months post-treatment21.
Hyaluronic acid fillers are among the most extensively studied aesthetic treatments:
Common, Expected Side Effects (typically resolve within 7–14 days):
Rare but Serious Complications (incidence <0.1%):
Why HA Fillers Are Considered the Gold Standard:
Reversibility. Unlike permanent fillers or fat transfer, HA can be dissolved immediately using hyaluronidase (an enzyme that breaks down hyaluronic acid). This makes HA fillers the safest choice for facial aesthetics, as any undesired result or complication can be reversed within hours27.
At BeReady, hyaluronidase is always on-site, and Dr. Abdulrahman Alhajri is trained in emergency complication management protocols as outlined by the British Association of Aesthetic Plastic Surgeons (BAAPS) and the British College of Aesthetic Medicine (BCAM).
Resilient Hyaluronic Acid (RHA®) fillers represent an advancement in cross-linking technology, designed to adapt to facial movement while maintaining structural support. Traditional fillers can sometimes appear stiff in dynamic areas (e.g., around the mouth or eyes). RHA fillers use a gentle manufacturing process that preserves the natural structure of HA, allowing greater flexibility and more natural movement28.
Key Benefits of RHA Fillers:
At BeReady:
We use RHA fillers selectively in patients who require subtlety and movement in expression-heavy areas, ensuring results that look natural in motion—not just in still photographs.
Section 03
The aging face undergoes four key processes7:
Natural results come from addressing the root causes of aging—not just erasing lines. This is why modern aesthetic medicine has shifted from a wrinkle-chasing approach to a structural, etiology-driven model.
This approach is supported by facial anatomy research, including landmark studies on fat compartment aging by Rohrich and Pessa, and the "5-point lift" technique developed by de Maio29.
A common misconception is that botulinum toxin "freezes" the face. In reality, skilled injectors use botulinum toxin to:
When administered with precision, patients retain full expressiveness—they simply don't develop deep etched lines from repetitive muscle contractions31.
At BeReady:
We use a conservative, anatomically informed approach to botulinum toxin. The goal is not to eliminate expression but to enhance natural beauty by preventing unnecessary wear and tear from hyperkinetic facial movements. Treatments are personalised based on muscle strength, skin thickness, and the patient's desired level of movement32.
Section 04
Injectable treatments are among the safest cosmetic procedures available—when performed correctly. However, the lack of regulation in the aesthetics industry means that not all practitioners have adequate training, and not all products are legitimate. Here's what evidence-based safety looks like.
The face contains a complex network of blood vessels, nerves, and tissue planes. Injecting without precise anatomical knowledge significantly increases the risk of:
At BeReady:
Dr. Abdulrahman Alhajri has completed advanced anatomical training, including cadaveric dissection courses and ultrasound-guided injection techniques. He uses aspiration techniques and slow injection speeds to minimise vascular risk, and all treatments are mapped to individual facial anatomy—not cookie-cutter templates.
The UK aesthetics market is flooded with counterfeit and unlicensed products. A 2019 investigation by Save Face found that 1 in 5 aesthetic clinics in the UK uses non-approved or counterfeit injectables34.
What sets approved products apart:
At BeReady:
We only use products from globally recognised brands with full UK regulatory approval. This includes Botox® and Azzalure® for botulinum toxin treatments, and Juvéderm®, Restylane®, and Teosyal® for dermal fillers. All products are sourced directly from licensed UK distributors, and batch records are maintained for every treatment.
Even with expert technique, complications can occur. What separates a safe clinic from an unsafe one is preparedness.
Essential safety measures:
At BeReady:
Our clinic follows the British Association of Cosmetic Nurses (BACN) and British College of Aesthetic Medicine (BCAM) guidelines for complication management. Dr. Alhajri is trained in emergency response, and hyaluronidase is available at every appointment. We also provide all patients with a 24-hour emergency contact line.
In the UK, botulinum toxin is classified as a prescription-only medicine (POM), meaning it can only be prescribed by a doctor, dentist, nurse prescriber, or pharmacist prescriber. Dermal fillers are not yet regulated in the same way, which has led to non-medically qualified individuals administering treatments without adequate training or oversight.
Why you should only see a qualified prescriber:
At BeReady:
Dr. Abdulrahman Alhajri is a fully qualified medical doctor registered with the General Medical Council (GMC). All prescriptions for botulinum toxin are issued following a face-to-face consultation, as required by UK law. We do not use loopholes such as remote prescribing or group prescriptions.
Section 05
One of the most important aspects of evidence-based aesthetics is honesty. Injectables are powerful tools, but they are not magic. Understanding what treatments can and cannot achieve is critical to patient satisfaction and safety.
Botulinum Toxin:
Dermal Fillers:
Studies consistently show that the most satisfied patients are those who:
A 2022 study published in the Aesthetic Surgery Journal found that patients who felt their practitioner "listened to their concerns and set realistic expectations" were 3.5 times more likely to report high satisfaction—even when results were modest36.
At BeReady:
We prioritise honest conversations over sales. If we don't believe a treatment will meaningfully improve your concerns, we will tell you—and suggest alternatives. Our goal is long-term trust, not short-term profit. Every treatment plan is individualised, evidence-based, and designed to enhance your natural features, not change who you are.
If you've read this far, you now know more about the science of injectable treatments than many people who've actually had them. You understand how these treatments work at a cellular and physiological level, what decades of clinical research actually shows, and why safety depends on practitioner knowledge and training.
This level of transparency isn't common in the aesthetic industry, where marketing often overshadows medicine. But if you're going to make an informed decision about having medical treatments, you deserve complete information—not simplified sales pitches.
